|
Volumn 3, Issue 2, 2014, Pages 252-264
|
Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia
a a a a |
Author keywords
Methylseleninic acid; prostate cancer; REDD1
|
Indexed keywords
DDIT4 PROTEIN, HUMAN;
DDIT4 PROTEIN, MOUSE;
METHYLSELENIC ACID;
ORGANOSELENIUM DERIVATIVE;
PROTEIN KINASE B;
REACTIVE OXYGEN METABOLITE;
TARGET OF RAPAMYCIN KINASE;
TRANSCRIPTION FACTOR;
ANIMAL;
APOPTOSIS;
CELL PROLIFERATION;
DRUG EFFECTS;
DRUG SCREENING;
ENZYME ACTIVATION;
ENZYMOLOGY;
HUMAN;
MALE;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
PROSTATIC NEOPLASMS;
TUMOR CELL CULTURE;
TUMOR CELL LINE;
ANIMALS;
APOPTOSIS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
ENZYME ACTIVATION;
HUMANS;
MALE;
MICE;
MICE, NUDE;
ORGANOSELENIUM COMPOUNDS;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-AKT;
REACTIVE OXYGEN SPECIES;
TOR SERINE-THREONINE KINASES;
TRANSCRIPTION FACTORS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 84922418015
PISSN: None
EISSN: 20457634
Source Type: Journal
DOI: 10.1002/cam4.198 Document Type: Article |
Times cited : (22)
|
References (0)
|